Standex Q4 sales rise 23.2% to $222.0 million; GAAP EPS falls to $1.23
Standex reported fiscal fourth-quarter 2025 results for the period ended June 30, 2025. Sales rose 23.2% year over year to $222.0 million, and adjusted EPS rose 20.6% to $2.28, while GAAP diluted EPS fell 25.9% to $1.23 from $1.66, reflecting higher amortization and acquisition-related costs tied to recent acquisitions. The company expects fiscal 2026 revenue to grow by more than $100 million.
Key points
- Q4 FY25 net sales were $222.0 million, up from $180.2 million a year earlier, with the Amran/Narayan Group acquisition a major contributor.
- GAAP diluted EPS was $1.23 versus $1.66 a year earlier; adjusted diluted EPS was $2.28 versus $1.89.
- Adjusted operating margin was 20.6%, up 350 basis points year over year; GAAP operating margin was 15.6%.
- For fiscal 2026, the company expects revenue to grow by over $100 million and fast growth market sales to exceed $265 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.